- Organon (OGN, Financial) stock shows potential despite recent declines, influenced by external pressures.
- Analysts project significant upside, with price targets suggesting a 67.26% increase.
- Current Hold rating reflects cautious optimism amid uncertain market conditions.
Organon (OGN) shares remain a topic of interest for investors, experiencing notable volatility even in the absence of significant news developments. This year, Organon has encountered various challenges, leading to a 24.8% year-to-date decline in stock value. Influences include foreign exchange headwinds and the impact of product exclusivity losses.
Wall Street Analysts Forecast
Analyst insights reveal an intriguing future for Organon & Co (OGN, Financial). With assessments from five analysts, the average one-year price target is $18.80, ranging from a high of $29.00 to a low of $11.00. This average target price signifies a potential upside of 67.26% compared to the current trading price of $11.24. For more detailed projections, visit the Organon & Co (OGN) Forecast page.
Industry consensus from eight brokerage firms currently places Organon & Co's (OGN, Financial) average brokerage recommendation at 3.0, equating to a "Hold" status. This scale, ranging from 1 (Strong Buy) to 5 (Sell), reflects a balanced perspective on the company's prospects.
According to GuruFocus estimates, Organon & Co (OGN, Financial) boasts a projected GF Value of $20.72 in the coming year, suggesting an 84.34% upside from its current price of $11.24. The GF Value provides an estimate of the stock's fair value, grounded in historical trading multiples, previous growth trends, and future business performance forecasts. Additional insights are available on the Organon & Co (OGN) Summary page.
